This company has been marked as potentially delisted and may not be actively trading. Oncorus (ONCR) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock ONCR Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period RFL Rafael Holdings, Inc.August 1, 2024 | seekingalpha.comOncorus Inc rdinary Shares Stock (OTC:ONCR) Dividends: History, Yield and DatesFebruary 26, 2024 | benzinga.comOncorus, Inc. (ONCR) stock price, news, quote & history – Yahoo FinanceDecember 29, 2023 | uk.finance.yahoo.comComera Life Sciences Holdings IncDecember 17, 2023 | investing.comOncorus Inc Ordinary SharesOctober 28, 2023 | morningstar.comMONCR Historical DataOctober 16, 2023 | investing.comOncorus (Nasdaq:ONCR) HeadlineTrading was temporarily halted for "ONCR" at 11:06 AM with a stated reason of "News pending."...June 20, 2023 | marketbeat.comWhat's Going On With Oncorus (ONCR) Stock Friday?June 16, 2023 | msn.comOncorus could file for bankruptcy as most employees laid off; down 43%June 2, 2023 | msn.comOncorus Announces Workforce Reduction PlanJune 1, 2023 | finance.yahoo.comOncorus, Inc.: Oncorus Reports First Quarter 2023 Financial Results and Provides Business UpdatesMay 23, 2023 | finanznachrichten.deRecap: Oncorus Q1 EarningsMay 22, 2023 | msn.comOncorus Reports First Quarter 2023 Financial Results and Provides Business UpdatesMay 22, 2023 | finance.yahoo.comOncorus, Inc.: Oncorus Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdatesMarch 24, 2023 | finanznachrichten.deOncorus Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdatesMarch 24, 2023 | finance.yahoo.comFor some biotechs moving on from SVB, not all traditional banks are an optionMarch 15, 2023 | bizjournals.com4 Stocks With Huge Cash Holdings at Silicon Valley Bank (ONCR)How the recent failure of Silicon Valley Bank leaves several companies with significant deposits stuck in the bank. Will regulators step in and save the day?March 13, 2023 | marketbeat.comRoku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed BankMarch 11, 2023 | markets.businessinsider.comOncorus Announces Research Collaboration with Daewoong Pharmaceutical for the Development of Lipid Nanoparticle Formulations for mRNA Drug CandidatesJanuary 4, 2023 | finance.yahoo.comOncorus Shares Plumb New Depths on Job Cuts, Portfolio Reshaping >ONCRNovember 30, 2022 | marketwatch.comOncorus Announces Portfolio Reprioritization to Focus on IV-Administered, Self-Amplifying RNA Medicines for Patients with CancerNovember 30, 2022 | finance.yahoo.comOncorus to Participate in Upcoming Investor ConferencesNovember 23, 2022 | finance.yahoo.comOncorus Presents Preclinical Data Supporting ONCR-719, an armed HSV-1 Vector engineered to use the Epidermal Growth Factor Receptor (EGFR/EGFRvIII) for viral entry in Glioblastoma, at the 2022 Society for Neuro-Oncology Annual MeetingNovember 18, 2022 | finance.yahoo.comOncorus, Inc. (ONCR) Moves to Buy: Rationale Behind the UpgradeNovember 7, 2022 | finance.yahoo.comRecap: Oncorus Q3 EarningsNovember 2, 2022 | msn.comOncorus, Inc. (NASDAQ: ONCR)October 8, 2022 | fool.comOncorus Announces Publication in Nature Communications Highlighting the Development of its Intravenously Administered Synthetic vRNA/LNP Platform for the Treatment of CancerOctober 7, 2022 | finance.yahoo.comOncorus: Top 10 Undervalued Healthcare Stocks on NAS (ONCR)October 5, 2022 | theglobeandmail.comOncorus to Present at Chardan's 6th Annual Genetic Medicines ConferenceSeptember 26, 2022 | benzinga.comOncorus to Present at Chardan’s 6th Annual Genetic Medicines ConferenceSeptember 26, 2022 | finance.yahoo.comOncorus to Present at the H.C. Wainwright 24th Annual Global Investment ConferenceSeptember 6, 2022 | finance.yahoo.comOncorus, Inc. (NASDAQ:ONCR) insiders recover some losses but still US$100k away from matching original investmentAugust 16, 2022 | finance.yahoo.comONCR.O - Oncorus Inc | Stock Price & Latest News | ReutersAugust 5, 2022 | reuters.comOncorus Reports Second Quarter 2022 Financial Results and Provides Business UpdatesAugust 4, 2022 | nz.finance.yahoo.comHere's Why Oncorus, Inc. (ONCR) Looks Ripe for Bottom FishingJuly 13, 2022 | finance.yahoo.comAn Intrinsic Calculation For Oncorus, Inc. (NASDAQ:ONCR) Suggests It's 44% UndervaluedJuly 6, 2022 | finance.yahoo.comOncorus Appoints Douglas Fambrough to Board of DirectorsJune 23, 2022 | finance.yahoo.comChardan Sees Over 200% Upside On This Small-Cap Cancer-Focused StockJune 15, 2022 | finance.yahoo.comChardan Capital Initiates Coverage On Oncorus with Buy Rating, Announces Price Target of $5 - Benzinga - BenzingaJune 15, 2022 | benzinga.comOncorus to Present at the Jefferies Global Healthcare Conference - Benzinga - BenzingaJune 1, 2022 | benzinga.comOncorus to Present at the Jefferies Global Healthcare ConferenceJune 1, 2022 | finance.yahoo.comOncorus : Statement of Changes in Beneficial Ownership (Form 4) - Marketscreener.comMay 26, 2022 | marketscreener.comMOncorus to Present at the H.C. Wainwright Global Investment ConferenceMay 17, 2022 | finance.yahoo.comForm DEF 14A Oncorus, Inc. For: Jun 22 - StreetInsider.comMay 13, 2022 | streetinsider.comOncorus Inc. (ONCR) Appoints Richard Wanstall as CFO - StreetInsider.comMay 10, 2022 | streetinsider.comGenascence Announces First Close in Series A Financing led by Pacira BioSciences and Expands Board of Directors and Scientific Advisory Board - PR NewswireMay 10, 2022 | prnewswire.comOncorus picks industry veteran for CFO role - Seeking AlphaMay 10, 2022 | seekingalpha.comOncorus Announces Appointment of Richard Wanstall as Chief Financial Officer - GlobeNewswireMay 10, 2022 | globenewswire.comOncorus Announces Appointment of Richard Wanstall as Chief Financial OfficerMay 10, 2022 | finance.yahoo.comOncorus Reports First Quarter 2022 Financial Results and Provides Business Updates - GlobeNewswireMay 4, 2022 | globenewswire.com Get Oncorus News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ONCR Media Mentions By Week ONCR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONCR News Sentiment▼0.000.92▲Average Medical News Sentiment ONCR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONCR Articles This Week▼00▲ONCR Articles Average Week Get the Latest News and Ratings for ONCR and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Oncorus and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AEON Biopharma News Matinas Biopharma News China Pharma News NeuroBo Pharmaceuticals News Spruce Biosciences News Oragenics News Avenue Therapeutics News Can-Fite BioPharma News Universe Pharmaceuticals News Vaccinex News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ONCR) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncorus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncorus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
